A detailed history of Rise Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Rise Advisors, LLC holds 1,420 shares of PFE stock, worth $37,942. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,420
Previous 1,406 1.0%
Holding current value
$37,942
Previous $39,000 5.13%
% of portfolio
0.02%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$27.7 - $31.39 $387 - $439
14 Added 1.0%
1,420 $41,000
Q2 2024

Jul 09, 2024

SELL
$25.26 - $29.6 $193,163 - $226,351
-7,647 Reduced 84.47%
1,406 $39,000
Q1 2024

Apr 09, 2024

BUY
$25.89 - $29.73 $25,605 - $29,402
989 Added 12.26%
9,053 $251,000
Q4 2023

Jan 10, 2024

SELL
$26.13 - $33.94 $26,913 - $34,958
-1,030 Reduced 11.33%
8,064 $232,000
Q3 2023

Oct 10, 2023

BUY
$32.09 - $37.51 $12,515 - $14,628
390 Added 4.48%
9,094 $301,000
Q2 2023

Jul 10, 2023

SELL
$36.12 - $41.79 $20,154 - $23,318
-558 Reduced 6.02%
8,704 $319,000
Q1 2023

Apr 05, 2023

BUY
$39.39 - $51.28 $27,809 - $36,203
706 Added 8.25%
9,262 $377,000
Q4 2022

Jan 06, 2023

BUY
$41.75 - $54.5 $17,326 - $22,617
415 Added 5.1%
8,556 $0
Q3 2022

Oct 11, 2022

BUY
$43.76 - $53.42 $10,108 - $12,340
231 Added 2.92%
8,141 $356,000
Q2 2022

Jul 28, 2022

BUY
$46.53 - $55.17 $38,573 - $45,735
829 Added 11.71%
7,910 $415,000
Q1 2022

Apr 22, 2022

BUY
$45.75 - $56.69 $54,122 - $67,064
1,183 Added 20.06%
7,081 $367,000
Q4 2021

Feb 24, 2022

BUY
$41.32 - $61.25 $243,705 - $361,252
5,898 New
5,898 $348 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Rise Advisors, LLC Portfolio

Follow Rise Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rise Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rise Advisors, LLC with notifications on news.